SCHEMBL17804309

SCHEMBL17804309

CC1(C)c2ccccc2C(c2ccc(-c3cc(-c4ccccc4)cc(-c4ccc(N5c6ccccc6C(C)(C)c6ccccc65)cc4)n3)cc2)c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
EGLN1 Q9GZT9 3/20 0.33
HTR2A P28223 1/20 0.33
CYP19A1 P11511 1/20 0.32
NTRK1 P04629 1/20 0.32
ADAMTS5 Q9UNA0 1/20 0.31
ADORA1 P30542 2/20 0.31
ADORA3 P0DMS8 1/20 0.31
ADORA2B P29275 1/20 0.31
BACE1 P56817 1/20 0.31
PDE6D O43924 1/20 0.30
MCL1 Q07820 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
MYC P01106 1/20 0.30
ADORA2A P29274 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18383121 0.89 KMT2A (0.41) MEN1KMT2AEGLN1CYP19A1ADAMTS5
SCHEMBL17830132 0.89 KMT2A (0.41) MEN1KMT2AEGLN1CYP19A1ADAMTS5
SCHEMBL22969712 0.86 MEN1 (0.39) MEN1KMT2AEGLN1CYP19A1ADORA1
SCHEMBL15084800 0.85 KMT2A (0.38) MEN1KMT2AEGLN1CYP19A1ADAMTS5
SCHEMBL17471194 0.83 HTR2A (0.37) KMT2AEGLN1HTR2AADAMTS5
SCHEMBL20230672 0.81 MEN1 (0.35) MEN1KMT2AEGLN1CYP19A1ADAMTS5
SCHEMBL15084796 0.81 MCL1 (0.41) MEN1KMT2AEGLN1CYP19A1MCL1
SCHEMBL17278605 0.81 MEN1 (0.45) MEN1KMT2AADORA1ADORA3ALDH1A1
SCHEMBL17278603 0.81 MEN1 (0.45) MEN1KMT2AADORA1ADORA3ALDH1A1
SCHEMBL13231648 0.81 ADAMTS5 (0.37) MEN1KMT2ACYP19A1ADAMTS5ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3029033-B1 COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING DEVICE UNIV KYUSHU NAT UNIV CORP (JP) 2021-06-16 EP disclosed
US-20160172600-A1 COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2016-06-16 US disclosed
US-20160172600-A1 COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2016-06-16 US disclosed
EP-3029033-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING DEVICE Kyushu University, National University Corporation (JP) 2016-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172600-A1 COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE NR2E3, ARL1, RER1 MEN1 1453/4885KMT2A 2217/4885EGLN1 2738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.